All Capsules

dmscarepharma dmscaren scaled

Hard-shell and modified-release capsules from a GMP manufacturer, in gelatin or vegetable HPMC shells, released against the pharmacopoeial monograph on your order.

Capsules: what the published guidance says

Capsules carry several WHO Model List entries where the shell is part of the specification — fluconazole 50 mg and omeprazole are listed as capsules rather than tablets, and for some molecules the capsule shell is what protects the active substance through the stomach.

  • Some Model List entries specify a capsule, not a tablet Fluconazole 50 mg is listed on the WHO Model List as a capsule. Where the listing names the shell form, an alternative oral solid is a different product for procurement purposes. Source
  • The shell can be functionally necessary For acid-labile molecules such as omeprazole the enteric or delayed-release presentation is the point of the product. Substituting an unprotected form changes the release behaviour, not just the appearance. Source
  • Shell material is a market decision Gelatin and HPMC (vegetable) shells are chemically different excipients. A growing number of markets requires a stated shell origin or a non-animal shell for religious or dietary labelling reasons. Source

What to fix in the specification

  • Fill weight and active content per capsule
  • Shell size (000–5) and material: gelatin or HPMC
  • Banding, sealing and tamper-evidence options
  • Immediate release or delayed / enteric release
  • Moisture content and shell brittleness limits
  • Blister or bottle pack, with pack count

Questions buyers ask

Do you supply HPMC (vegetable) capsules as well as gelatin?

Yes. Both shell materials are available and the choice is recorded in the specification, since several markets require a stated shell origin on the dossier.

Can you produce banded or tamper-evident capsules?

Yes — banding and sealing are agreed as part of the specification and shown on the artwork and batch record.

Are enteric capsules available?

Delayed-release and enteric-protected presentations are produced where the molecule requires it, with the corresponding release testing in the dossier.

Ordering and documentation

Every line is quoted against a written specification: monograph, strength, pack configuration, release tests and the documents that ship with the batch. Certificates of analysis, stability data and the GMP certificate accompany each consignment; dossier and registration support are provided where the market requires a filing.

Send a requirement · full product catalogue · therapeutic ranges

Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.